(firstQuint)A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache.

 This study is a multi-center, triple-blinded, placebo-controlled, randomized clinical trial for adjunctive prophylactic treatment of episodic migraine headache (with or without aura) using neuromodulation device developed by Scion NeuroStim, LLC (SNS).

 The investigational use of the device for episodic migraine headache has been reviewed by the FDA and is classified as NSR (non-significant risk).

.

 A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache@highlight

This study will assess the efficacy of a neuromodulation device for the treatment of episodic migraine headache.

